1. Home
  2. OKYO vs CPIX Comparison

OKYO vs CPIX Comparison

Compare OKYO & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.59

Market Cap

83.4M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$5.03

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OKYO
CPIX
Founded
2007
1999
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
73.6M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
OKYO
CPIX
Price
$1.59
$5.03
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.33
N/A
AVG Volume (30 Days)
43.0K
1.9M
Earning Date
07-18-2025
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$1.44
$1.85
52 Week High
$3.35
$6.27

Technical Indicators

Market Signals
Indicator
OKYO
CPIX
Relative Strength Index (RSI) 47.69 70.34
Support Level $1.58 $2.81
Resistance Level $1.73 $5.38
Average True Range (ATR) 0.07 0.34
MACD -0.00 0.08
Stochastic Oscillator 32.86 78.97

Price Performance

Historical Comparison
OKYO
CPIX

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: